Matthias Kroiß

16.8k total citations · 1 hit paper
174 papers, 4.7k citations indexed

About

Matthias Kroiß is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Matthias Kroiß has authored 174 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Surgery, 100 papers in Endocrinology, Diabetes and Metabolism and 79 papers in Cancer Research. Recurrent topics in Matthias Kroiß's work include Adrenal and Paraganglionic Tumors (95 papers), Cancer, Hypoxia, and Metabolism (72 papers) and Hormonal Regulation and Hypertension (49 papers). Matthias Kroiß is often cited by papers focused on Adrenal and Paraganglionic Tumors (95 papers), Cancer, Hypoxia, and Metabolism (72 papers) and Hormonal Regulation and Hypertension (49 papers). Matthias Kroiß collaborates with scholars based in Germany, United States and Switzerland. Matthias Kroiß's co-authors include Martin Faßnacht, Bruno Allolio, Cristina L. Ronchi, Marcus Quinkler, Silviu Sbiera, Stefanie Hahner, Rossella Libé, Felix Beuschlein, Timo Deutschbein and Barbara Altieri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Kroiß

161 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Personalized Management of Pheochromocytoma and Paraganglioma

2021 200 citations Svenja Nölting, Nicole Bechmann et al. Endocrine Reviews profile →

Peers

Countries citing papers authored by Matthias Kroiß

Since Specialization

Citations

This map shows the geographic impact of Matthias Kroiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Kroiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Kroiß more than expected).

Fields of papers citing papers by Matthias Kroiß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Kroiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Kroiß. The network helps show where Matthias Kroiß may publish in the future.

Co-authorship network of co-authors of Matthias Kroiß

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Kroiß. A scholar is included among the top collaborators of Matthias Kroiß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Kroiß. Matthias Kroiß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preoperative Management of Catecholamine-Producing Pheochromocytomas and Paragangliomas—Results From a DELPHI Process 2025 ·Journal of the Endocrine Society ·Nicole Bechmann, Costanza Chiapponi, (unknown), Christian Grasshoff, Petra Zimmermann, Martin K. Walz, Martina T. Mogl, Volker Fendrich, Katharina Holzer, Nada Rayes, Matthias Kroiß	0
2	Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Laura‐Sophie Landwehr, Barbara Altieri, Iuliu Sbiera, Hanna Remde, Stefan Kircher, (unknown), Silviu Sbiera, Matthias Kroiß, Martin Faßnacht	11
3	Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch 2024 ·npj Precision Oncology ·Barbara Deschler-Baier, (unknown), Matthias Kroiß, Manik Chatterjee, Daniel Gündel, (unknown), Alexander Kerscher, Volker Kunzmann, Silke Appenzeller, Katja Maurus, Andreas Rosenwald, Ralf C. Bargou, Elena Hartmann, Vivek Venkataramani	0
4	The Value of Local Therapies in Advanced Adrenocortical Carcinoma 2024 ·Cancers ·(unknown), Barbara Altieri, Marta Laganà, Thomas J. Vogl, (unknown), Tina Dušek, Vittoria Basile, (unknown), Ulrich Dischinger, Marcus Quinkler, Matthias Kroiß, Soraya Puglisi, Deborah Cosentini, Ralph Kickuth, Darko Kaštelan, Martin Faßnacht	4
5	The impact of acyl-CoA:cholesterol transferase (ACAT) inhibitors on biophysical membrane properties depends on membrane lipid composition 2024 ·Molecular and Cellular Endocrinology ·Huong Thi Mai To, Peter Reinholdt, (unknown), Meike Luck, Line Lauritsen, (unknown), Matthias Kroiß, Daniel Wüstner, Jacob Kongsted, Peter Müller, Holger A. Scheidt	1
6	Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 2024 ·European Journal of Endocrinology ·Barbara Altieri, (unknown), Felix Megerle, (unknown), Irina Chifu, Carmina Teresa Fuß, Marcus Quinkler, Matthias Kroiß, Martin Faßnacht	2
7	Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 2023 ·European Journal of Endocrinology ·(unknown), Katrin Ritzel, (unknown), Marie Helene Schernthaner-Reiter, Marco Losa, (unknown), Barbara Altieri, Matthias Kroiß, Ralph Kickuth, Martin Faßnacht, Alexander Micko, Jürgen Honegger, Martín Reincke, Timo Deutschbein	13
8	Adrenal Crisis – Definition, Prevention and Treatment: Results from a Delphi Survey 2023 ·Hormone and Metabolic Research ·Tina Kienitz, Nicole Bechmann, Timo Deutschbein, Stefanie Hahner, Jürgen Honegger, Matthias Kroiß, Marcus Quinkler, Nada Rayes, Nicole Reisch, Holger S. Willenberg, Gesine Meyer	3
9	Deep Learning Approaches Applied to Image Classification of Renal Tumors: A Systematic Review 2023 ·Archives of Computational Methods in Engineering ·(unknown), Felix Beuschlein, (unknown), Judith Favier, David Gil, (unknown), Ronald R. de Krijger, Matthias Kroiß, (unknown), Attila Patócs, Anthony Stell, Axel Walch	6
10	High-Dose Rate Brachytherapy Combined with PD-1 Blockade as a Treatment for Metastatic Adrenocortical Carcinoma – A Single Center Case Series 2023 ·Hormone and Metabolic Research ·(unknown), Stefanie Corradini, Max Seidensticker, Petra Zimmermann, Jochen Schreiner, Tanja Maier, (unknown), Thomas Knösel, Montserrat Pazos, Thomas Pfluger, Isabel Weigand, Claus Belka, Jens Ricke, Martín Reincke, Ralf Schmidmaier, Matthias Kroiß	4
11	Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors 2023 ·Clinica Chimica Acta ·(unknown), Tobias Müller, (unknown), Thomas Dandekar, Anna Riester, Ulrich Dischinger, Max Kurlbaum, Matthias Kroiß, Martin Faßnacht	10
12	Targeting 11-Beta Hydroxylase With [131I]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Stefanie Hahner, Philipp E. Hartrampf, (unknown), (unknown), Britta Heinze, Heribert Hänscheid, Carmina Teresa Fuß, Rudolf A. Werner, Christina Pamporaki, Matthias Kroiß, Martin Faßnacht, Andreas K. Buck, Andreas Schirbel	8
13	Steroid Sulfation in Adrenal Tumors 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Jonathan Wolf Mueller, (unknown), (unknown), Isabel Weigand, Cristina L. Ronchi, Paul Foster, Matthias Kroiß	10
14	Personalized Management of Pheochromocytoma and Paraganglioma breakdown → 2021 ·Endocrine Reviews ·Svenja Nölting, Nicole Bechmann, David Taïeb, Felix Beuschlein, Martin Faßnacht, Matthias Kroiß, Graeme Eisenhofer, Ashley Grossman, Karel Pacák	200
15	Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Isabel Weigand, Barbara Altieri, (unknown), Vittoria Basile, Stefan Kircher, Laura‐Sophie Landwehr, Jochen Schreiner, Maria Cláudia Nogueira Zerbini, Cristina L. Ronchi, Felix Megerle, Alfredo Berruti, Letizia Canu, Marco Volante, Isabel Paiva, Silvia Della Casa, Silviu Sbiera, Martin Faßnacht, Maria Candida Barisson Villares Fragoso, Massimo Terzolo, Matthias Kroiß	21
16	Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology 2020 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Julia Wendler, Karin Frank‐Raue, Michael C. Kreißl, Christine Spitzweg, Martin Faßnacht, Friedhelm Raue, Matthias Kroiß	10
17	Disease Progression after Discontinuation of Nivolumab for Intolerable ImmunotherapyAssociated Polymyalgia Rheumatica in a Patient with Metastasized Adrenocortical Carcinoma: A Case Report and Review of the Literature 2020 ·Dennis Christoph Harrer, (unknown), (unknown), Matthias Kroiß, D. Hellwig, (unknown), Tobias Pukrop, Martin Vogelhuber	1
18	No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS 2014 ·Clinica Chimica Acta ·(unknown), Matthias Kroiß, Martin Faßnacht, Michael Vogeser	49
19	Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP 2008 ·Human Molecular Genetics ·Bastian Linder, Oliver Plöttner, Matthias Kroiß, Enno Hartmann, Bernhard Laggerbauer, Gunter Meister, (unknown), Utz Fischer	66
20	Benefits of alpine mountain climate of Bavaria in patients with allergic diseases results from the AURA - Study 2007 ·mediaTUM (Technical University of Munich) ·Bernadette Eberlein, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sidnei Luís Bohn Gass, Matthias Kroiß, Johannes Huss‐Marp, Ulf Darsow, Regina Hollweck, Tibor Schuster, Horst Behrendt, J Ring	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact